11-49154258-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000256999.7(FOLH1):c.1858C>A(p.Gln620Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,320 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000256999.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOLH1 | NM_004476.3 | c.1858C>A | p.Gln620Lys | missense_variant | 16/19 | ENST00000256999.7 | NP_004467.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOLH1 | ENST00000256999.7 | c.1858C>A | p.Gln620Lys | missense_variant | 16/19 | 1 | NM_004476.3 | ENSP00000256999 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250598Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135404
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461196Hom.: 1 Cov.: 30 AF XY: 0.0000550 AC XY: 40AN XY: 726912
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.1858C>A (p.Q620K) alteration is located in exon 16 (coding exon 16) of the FOLH1 gene. This alteration results from a C to A substitution at nucleotide position 1858, causing the glutamine (Q) at amino acid position 620 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at